Valuation Black Diamond Therapeutics, Inc. OTC Markets
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index | CI |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark | CI |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 100.9 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -27.16% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 100.9 | 100.9 | 100.9 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -27.16% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -2.72x | -1.75x | -1.68x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | -0.4x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 18.2x | - | - |
| EV / Revenue | - | - | - | - | 0x | 18.2x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.17x | -1.97x | -1.58x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.26x | -1.36x | -1.03x |
| EV / FCF | 0x | 0x | -0x | -0x | 0x | -2.4x | -2.29x | 6.3x |
| FCF Yield | -53.3% | -130% | -46% | -51.5% | 21.4% | -41.6% | -43.6% | 15.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6478 | -1.005 | -1.047 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 5.556 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -46.4 | -51.15 | -63.9 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -44.69 | -74.05 | -97.58 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -40.47 | -70.04 | -94.17 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.760 | 1.760 | 1.760 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,302 | - | - |
| Announcement Date | 3/17/22 | 3/9/23 | 3/12/24 | 3/6/25 | 3/16/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.11x | 8.21x | 25.31x | 0.04% | 56.19B | |
| 20.62x | 6.35x | 13.89x | 1.54% | 54.83B | |
| -18.25x | 4.33x | -7.59x | -.--% | 23.04B | |
| -41x | 13.02x | -38.35x | -.--% | 22.7B | |
| 25.46x | 4.98x | 13.19x | -.--% | 20.23B | |
| 24.92x | 4.83x | 15.71x | -.--% | 17.83B | |
| -786.44x | 37.38x | -4208.26x | -.--% | 15.65B | |
| 45.88x | 18.59x | 47.88x | 0.08% | 15.24B | |
| 17.56x | 5.09x | 11.87x | -.--% | 14.03B | |
| Average | -75.35x | 11.42x | -458.48x | 0.19% | 26.64B | |
| Weighted average by Cap. | -36.56x | 9.73x | -263.99x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
